1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Viral Detection Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Plaque Assays
  • 1.2.3 PCR
  • 1.2.4 ELISA
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Viral Detection Market Share by Application: 2020 VS 2026
  • 1.3.2 Blood & Blood Products
  • 1.3.3 Cellular & Gene Therapy Products
  • 1.3.4 Stem Cell Products
  • 1.3.5 Tissue & Tissue Products
  • 1.3.6 Vaccines and Therapeutics
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Viral Detection Market Perspective (2015-2026)
• 2.2 Global Viral Detection Growth Trends by Regions
  • 2.2.1 Viral Detection Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Viral Detection Historic Market Share by Regions (2015-2020)
  • 2.2.3 Viral Detection Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Viral Detection Players by Market Size
  • 3.1.1 Global Top Viral Detection Players by Revenue (2015-2020)
  • 3.1.2 Global Viral Detection Revenue Market Share by Players (2015-2020)
• 3.2 Global Viral Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Viral Detection Revenue
• 3.4 Global Viral Detection Market Concentration Ratio
  • 3.4.1 Global Viral Detection Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Viral Detection Revenue in 2019
• 3.5 Key Players Viral Detection Area Served
• 3.6 Key Players Viral Detection Product Solution and Service
• 3.7 Date of Enter into Viral Detection Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Detection Breakdown Data by Type (2015-2026)

• 4.1 Global Viral Detection Historic Market Size by Type (2015-2020)
• 4.2 Global Viral Detection Forecasted Market Size by Type (2021-2026)

5 Viral Detection Breakdown Data by Application (2015-2026)

• 5.1 Global Viral Detection Historic Market Size by Application (2015-2020)
• 5.2 Global Viral Detection Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Viral Detection Market Size (2015-2026)
• 6.2 North America Viral Detection Market Size by Type (2015-2020)
• 6.3 North America Viral Detection Market Size by Application (2015-2020)
• 6.4 North America Viral Detection Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Viral Detection Market Size (2015-2026)
• 7.2 Europe Viral Detection Market Size by Type (2015-2020)
• 7.3 Europe Viral Detection Market Size by Application (2015-2020)
• 7.4 Europe Viral Detection Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Viral Detection Market Size (2015-2026)
• 8.2 China Viral Detection Market Size by Type (2015-2020)
• 8.3 China Viral Detection Market Size by Application (2015-2020)
• 8.4 China Viral Detection Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Viral Detection Market Size (2015-2026)
• 9.2 Japan Viral Detection Market Size by Type (2015-2020)
• 9.3 Japan Viral Detection Market Size by Application (2015-2020)
• 9.4 Japan Viral Detection Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Viral Detection Market Size (2015-2026)
• 10.2 Southeast Asia Viral Detection Market Size by Type (2015-2020)
• 10.3 Southeast Asia Viral Detection Market Size by Application (2015-2020)
• 10.4 Southeast Asia Viral Detection Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Avance Biosciences Inc. (U.S.)
  • 11.1.1 Avance Biosciences Inc. (U.S.) Company Details
  • 11.1.2 Avance Biosciences Inc. (U.S.) Business Overview
  • 11.1.3 Avance Biosciences Inc. (U.S.) Viral Detection Introduction
  • 11.1.4 Avance Biosciences Inc. (U.S.) Revenue in Viral Detection Business (2015-2020))
  • 11.1.5 Avance Biosciences Inc. (U.S.) Recent Development
• 11.2 BSL BIOSERVICE (Germany)
  • 11.2.1 BSL BIOSERVICE (Germany) Company Details
  • 11.2.2 BSL BIOSERVICE (Germany) Business Overview
  • 11.2.3 BSL BIOSERVICE (Germany) Viral Detection Introduction
  • 11.2.4 BSL BIOSERVICE (Germany) Revenue in Viral Detection Business (2015-2020)
  • 11.2.5 BSL BIOSERVICE (Germany) Recent Development
• 11.3 Clean Cells (France)
  • 11.3.1 Clean Cells (France) Company Details
  • 11.3.2 Clean Cells (France) Business Overview
  • 11.3.3 Clean Cells (France) Viral Detection Introduction
  • 11.3.4 Clean Cells (France) Revenue in Viral Detection Business (2015-2020)
  • 11.3.5 Clean Cells (France) Recent Development
• 11.4 Charles River Laboratories International, Inc. (U.S.)
  • 11.4.1 Charles River Laboratories International, Inc. (U.S.) Company Details
  • 11.4.2 Charles River Laboratories International, Inc. (U.S.) Business Overview
  • 11.4.3 Charles River Laboratories International, Inc. (U.S.) Viral Detection Introduction
  • 11.4.4 Charles River Laboratories International, Inc. (U.S.) Revenue in Viral Detection Business (2015-2020)
  • 11.4.5 Charles River Laboratories International, Inc. (U.S.) Recent Development
• 11.5 Lonza Group (Switzerland)
  • 11.5.1 Lonza Group (Switzerland) Company Details
  • 11.5.2 Lonza Group (Switzerland) Business Overview
  • 11.5.3 Lonza Group (Switzerland) Viral Detection Introduction
  • 11.5.4 Lonza Group (Switzerland) Revenue in Viral Detection Business (2015-2020)
  • 11.5.5 Lonza Group (Switzerland) Recent Development
• 11.6 Merck KGaA (Germany)
  • 11.6.1 Merck KGaA (Germany) Company Details
  • 11.6.2 Merck KGaA (Germany) Business Overview
  • 11.6.3 Merck KGaA (Germany) Viral Detection Introduction
  • 11.6.4 Merck KGaA (Germany) Revenue in Viral Detection Business (2015-2020)
  • 11.6.5 Merck KGaA (Germany) Recent Development
• 11.7 Sigma-Aldrich Corporation (U.S.)
  • 11.7.1 Sigma-Aldrich Corporation (U.S.) Company Details
  • 11.7.2 Sigma-Aldrich Corporation (U.S.) Business Overview
  • 11.7.3 Sigma-Aldrich Corporation (U.S.) Viral Detection Introduction
  • 11.7.4 Sigma-Aldrich Corporation (U.S.) Revenue in Viral Detection Business (2015-2020)
  • 11.7.5 Sigma-Aldrich Corporation (U.S.) Recent Development
• 11.8 SGS S.A. (Switzerland)
  • 11.8.1 SGS S.A. (Switzerland) Company Details
  • 11.8.2 SGS S.A. (Switzerland) Business Overview
  • 11.8.3 SGS S.A. (Switzerland) Viral Detection Introduction
  • 11.8.4 SGS S.A. (Switzerland) Revenue in Viral Detection Business (2015-2020)
  • 11.8.5 SGS S.A. (Switzerland) Recent Development
• 11.9 Texcell, Inc. (France)
  • 11.9.1 Texcell, Inc. (France) Company Details
  • 11.9.2 Texcell, Inc. (France) Business Overview
  • 11.9.3 Texcell, Inc. (France) Viral Detection Introduction
  • 11.9.4 Texcell, Inc. (France) Revenue in Viral Detection Business (2015-2020)
  • 11.9.5 Texcell, Inc. (France) Recent Development
• 11.10 WuXi PharmaTech (Cayman) Inc. (China)
  • 11.10.1 WuXi PharmaTech (Cayman) Inc. (China) Company Details
  • 11.10.2 WuXi PharmaTech (Cayman) Inc. (China) Business Overview
  • 11.10.3 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Introduction
  • 11.10.4 WuXi PharmaTech (Cayman) Inc. (China) Revenue in Viral Detection Business (2015-2020)
  • 11.10.5 WuXi PharmaTech (Cayman) Inc. (China) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Viral Detection Scope and Market Size
Viral Detection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Detection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Plaque Assays
PCR
ELISA
Others

Market segment by Application, split into
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics

Based on regional and country-level analysis, the Viral Detection market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Viral Detection market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Avance Biosciences Inc. (U.S.)
BSL BIOSERVICE (Germany)
Clean Cells (France)
Charles River Laboratories International, Inc. (U.S.)
Lonza Group (Switzerland)
Merck KGaA (Germany)
Sigma-Aldrich Corporation (U.S.)
SGS S.A. (Switzerland)
Texcell, Inc. (France)
WuXi PharmaTech (Cayman) Inc. (China)